This prompted the suggestion that TUBB3 expression may contribute to the maintenance of CSCs in bladder cancer (Namekawa et al., 2020), which could account for why elevated TUBB3 is observed with more aggressive subtypes of bladder cancer (Hinsch et al., 2017). This evidence concerns the gene TUBB3 and urinary bladder cancer.